These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

366 related items for PubMed ID: 11773207

  • 1. Growth hormone and sex steroid effects on bone metabolism and bone mineral density in healthy aged women and men.
    Christmas C, O'Connor KG, Harman SM, Tobin JD, Münzer T, Bellantoni MF, Clair CS, Pabst KM, Sorkin JD, Blackman MR.
    J Gerontol A Biol Sci Med Sci; 2002 Jan; 57(1):M12-8. PubMed ID: 11773207
    [Abstract] [Full Text] [Related]

  • 2. Endogenous sex steroid, GH and IGF-I levels in normal elderly men: relationships with bone mineral density and markers of bone turnover.
    Gürlek A, Gedik O.
    J Endocrinol Invest; 2001 Jun; 24(6):408-14. PubMed ID: 11434664
    [Abstract] [Full Text] [Related]

  • 3. Effects of GH and/or sex steroids on circulating IGF-I and IGFBPs in healthy, aged women and men.
    Münzer T, Rosen CJ, Harman SM, Pabst KM, St Clair C, Sorkin JD, Blackman MR.
    Am J Physiol Endocrinol Metab; 2006 May; 290(5):E1006-13. PubMed ID: 16390864
    [Abstract] [Full Text] [Related]

  • 4. Skeletal effects of cyclic recombinant human growth hormone and salmon calcitonin in osteopenic postmenopausal women.
    Holloway L, Kohlmeier L, Kent K, Marcus R.
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1111-7. PubMed ID: 9100582
    [Abstract] [Full Text] [Related]

  • 5. Growth hormone and sex steroid administration in healthy aged women and men: a randomized controlled trial.
    Blackman MR, Sorkin JD, Münzer T, Bellantoni MF, Busby-Whitehead J, Stevens TE, Jayme J, O'Connor KG, Christmas C, Tobin JD, Stewart KJ, Cottrell E, St Clair C, Pabst KM, Harman SM.
    JAMA; 2002 Nov 13; 288(18):2282-92. PubMed ID: 12425705
    [Abstract] [Full Text] [Related]

  • 6. Effects of growth hormone (GH) replacement on bone metabolism and mineral density in adult onset of GH deficiency: results of a double-blind placebo-controlled study with open follow-up.
    Finkenstedt G, Gasser RW, Höfle G, Watfah C, Fridrich L.
    Eur J Endocrinol; 1997 Mar 13; 136(3):282-9. PubMed ID: 9100553
    [Abstract] [Full Text] [Related]

  • 7. Growth hormone and sex steroid effects on serum glucose, insulin, and lipid concentrations in healthy older women and men.
    Münzer T, Harman SM, Sorkin JD, Blackman MR.
    J Clin Endocrinol Metab; 2009 Oct 13; 94(10):3833-41. PubMed ID: 19602554
    [Abstract] [Full Text] [Related]

  • 8. Effect of alendronate and MK-677 (a growth hormone secretagogue), individually and in combination, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic women.
    Murphy MG, Weiss S, McClung M, Schnitzer T, Cerchio K, Connor J, Krupa D, Gertz BJ, MK-677/Alendronate Study Group.
    J Clin Endocrinol Metab; 2001 Mar 13; 86(3):1116-25. PubMed ID: 11238495
    [Abstract] [Full Text] [Related]

  • 9. Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study.
    Morabito N, Crisafulli A, Vergara C, Gaudio A, Lasco A, Frisina N, D'Anna R, Corrado F, Pizzoleo MA, Cincotta M, Altavilla D, Ientile R, Squadrito F.
    J Bone Miner Res; 2002 Oct 13; 17(10):1904-12. PubMed ID: 12369794
    [Abstract] [Full Text] [Related]

  • 10. [Long-term effects of 7-year growth hormone substitution on bone metabolism, bone density, and bone quality in growth hormone-deficient adults].
    Wilhelm B, Kann PH.
    Med Klin (Munich); 2004 Oct 15; 99(10):569-77. PubMed ID: 15490072
    [Abstract] [Full Text] [Related]

  • 11. Effects of suppression of estrogen action by the p450 aromatase inhibitor letrozole on bone mineral density and bone turnover in pubertal boys.
    Wickman S, Kajantie E, Dunkel L.
    J Clin Endocrinol Metab; 2003 Aug 15; 88(8):3785-93. PubMed ID: 12915670
    [Abstract] [Full Text] [Related]

  • 12. Effect of long-term growth-hormone substitution therapy on bone mineral density and parameters of bone metabolism in adult patients with growth hormone deficiency.
    Kotzmann H, Riedl M, Bernecker P, Clodi M, Kainberger F, Kaider A, Woloszczuk W, Luger A.
    Calcif Tissue Int; 1998 Jan 15; 62(1):40-6. PubMed ID: 9405732
    [Abstract] [Full Text] [Related]

  • 13. Effects of 12 months of recombinant growth hormone therapy on parameters of bone metabolism and bone mineral density in patients on chronic hemodialysis.
    Kotzmann H, Riedl M, Pietschmann P, Schmidt A, Schuster E, Kreuzer S, Kainberger F, Frisch H, Geyer G, Hörl WH, Mayer G, Luger A.
    J Nephrol; 2004 Jan 15; 17(1):87-94. PubMed ID: 15151263
    [Abstract] [Full Text] [Related]

  • 14. Sublingual administration of micronized estradiol and progesterone, with and without micronized testosterone: effect on biochemical markers of bone metabolism and bone mineral density.
    Miller BE, De Souza MJ, Slade K, Luciano AA.
    Menopause; 2000 Jan 15; 7(5):318-26. PubMed ID: 10993031
    [Abstract] [Full Text] [Related]

  • 15. The predictive value of biochemical markers of bone turnover for bone mineral density in early postmenopausal women treated with hormone replacement or calcium supplementation.
    Rosen CJ, Chesnut CH, Mallinak NJ.
    J Clin Endocrinol Metab; 1997 Jun 15; 82(6):1904-10. PubMed ID: 9177404
    [Abstract] [Full Text] [Related]

  • 16. The effect of short- and long-term growth hormone treatment on bone mineral density and bone metabolism of prepubertal children with idiopathic short stature: a 3-year study.
    Lanes R, Gunczler P, Esaa S, Weisinger JR.
    Clin Endocrinol (Oxf); 2002 Dec 15; 57(6):725-30. PubMed ID: 12460321
    [Abstract] [Full Text] [Related]

  • 17. Effects of GH and/or sex steroid administration on abdominal subcutaneous and visceral fat in healthy aged women and men.
    Münzer T, Harman SM, Hees P, Shapiro E, Christmas C, Bellantoni MF, Stevens TE, O'Connor KG, Pabst KM, St Clair C, Sorkin JD, Blackman MR.
    J Clin Endocrinol Metab; 2001 Aug 15; 86(8):3604-10. PubMed ID: 11502785
    [Abstract] [Full Text] [Related]

  • 18. Long-term maintenance of the anabolic effects of GH on the skeleton in successfully treated patients with acromegaly.
    Biermasz NR, Hamdy NA, Pereira AM, Romijn JA, Roelfsema F.
    Eur J Endocrinol; 2005 Jan 15; 152(1):53-60. PubMed ID: 15762187
    [Abstract] [Full Text] [Related]

  • 19. Effects of long-term treatment with GH in the bone mineral density of adults with hypopituitarism and GH deficiency and after discontinuation of GH replacement.
    Gómez JM, Gómez N, Fiter J, Soler J.
    Horm Metab Res; 2000 Feb 15; 32(2):66-70. PubMed ID: 10741688
    [Abstract] [Full Text] [Related]

  • 20. The influence of gender on the short and long-term effects of growth hormone replacement on bone metabolism and bone mineral density in hypopituitary adults: a 5-year study.
    Drake WM, Rodríguez-Arnao J, Weaver JU, James IT, Coyte D, Spector TD, Besser GM, Monson JP.
    Clin Endocrinol (Oxf); 2001 Apr 15; 54(4):525-32. PubMed ID: 11318789
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.